Profile
| Metric | Value |
|---|---|
| Full Name | Envista Holdings Corporation |
| Ticker | NYSE: NVST |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | envistaco.com |
| Employees | 12,300 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $23.55 | |
| Price, 1D Change | -0.30% | |
| Market Cap | $4B | |
| - | ||
| PE Ratio | 281.70 | |
| Beta | 1.29 | |
| Revenue | $3B | |
| Revenue, 1Y Change | -2.18% | |
| EPS | -$6.50 | |
| EPS, 1Y Change | -981.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$6.50 | |
| EPS Estimate | $1.14 | |
| EPS Est. Change | +117.55% | |
| Revenue | $2.51B | |
| Revenue Estimate | $2.64B | |
| Revenue Est. Change | +5.35% | |
| Current Price | $23.55 | |
| Price Target | - | $22.00 |
| Price Tgt. Change | - | -6.58% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.59 | -$0.60 | -137.76% | |
| $0.71 | -$6.50 | -1,011.32% | |
| $1.14 | N/A | +117.55% | |
| $1.27 | N/A | +119.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.56B | $2.57B | +0.34% | |
| $2.50B | $2.51B | +0.26% | |
| $2.64B | N/A | +5.35% | |
| $2.74B | N/A | +9.13% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +22.85% | |
| Price, 3Y | -28.53% | |
| Market Cap, 1Y | +17.30% | |
| Market Cap, 3Y | -27.99% | |
| Revenue, 1Y | -2.18% | |
| Revenue, 3Y | +0.07% | |
| EPS, 1Y | -981.93% | |
| EPS, 3Y | -450.86% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $23.55 | |
| SMA 200 | $19.54 | |
| SMA 200 vs Price | -17.03% | |
| SMA 50 | $20.91 | |
| SMA 50 vs Price | -11.21% | |
| Beta | 1.29 | |
| ATR | $0.60 | |
| 14-Day RSI | 70.85 | |
| 10-Day Volatility | 29.30% | |
| 1-Year Volatility | 39.86% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.51B | |
| EPS | -$6.50 | |
| Gross Profit | $1.37B | |
| Gross Margin | 54.68% | |
| Operating Profit | $115.60M | |
| Operating Margin | 4.60% | |
| Net Income | -$1.12B | |
| Net Margin | -44.56% | |
| EBITDA | -$883.80M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.53 | |
| Current Ratio | 2.04 | |
| Quick Ratio | 1.76 | |
| - | ||
| F-Score | 8 | |
| Altman Z-Score | 0.83 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 281.70 | |
| PS Ratio | 1.48 | |
| PB Ratio | 1.25 | |
| EV/EBITDA | 12.77 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $2.93B | |
| Cash & Equivalents | $1.07B | |
| Total Assets | $5.45B | |
| Current Assets | $1.79B | |
| Total Liabilities | $2.52B | |
| Current Liabilities | $878.70M | |
| Total Debt | $1.55B | |
| Short Term Debt | $150.50M | |
| Accounts Payable | $174.60M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.40B | |
| Operating Expenses | $1.26B | |
| Cost Of Goods Sold | $1.14B | |
| SG&A | $1.16B | |
| D&A | $154.50M | |
| Interest Expense | $0.00 | |
| Income Tax | $33.90M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $336.50M | |
| CFI | -$54.60M | |
| CFF | -$103.70M | |
| Capex | $33.80M | |
| Free Cash Flow | $302.70M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| JP Morgan | → | |
| Barclays | ||
| Wells Fargo | → | |
| Stifel | → | |
| Piper Sandler | → | |
| Morgan Stanley | → | |
| Mizuho | → | |
| UBS | → | |
| Evercore ISI Group | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with NVST
Data Sources & References
- NVST Official Website envistaco.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1757073/000175707325000058/0001757073-25-000058-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1757073/000175707325000007/0001757073-25-000007-index.htm
- NVST Profile on Yahoo Finance finance.yahoo.com/quote/NVST
- NVST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvst
FAQ
What is the ticker symbol for Envista Holdings Corporation?
The ticker symbol for Envista Holdings Corporation is NYSE:NVST
Does Envista Holdings Corporation pay dividends?
No, Envista Holdings Corporation does not pay dividends
What sector is Envista Holdings Corporation in?
Envista Holdings Corporation is in the Healthcare sector
What industry is Envista Holdings Corporation in?
Envista Holdings Corporation is in the Medical Instruments & Supplies industry
What country is Envista Holdings Corporation based in?
Envista Holdings Corporation is headquartered in United States
When did Envista Holdings Corporation go public?
Envista Holdings Corporation initial public offering (IPO) was on September 18, 2019
Is Envista Holdings Corporation in the S&P 500?
No, Envista Holdings Corporation is not included in the S&P 500 index
Is Envista Holdings Corporation in the NASDAQ 100?
No, Envista Holdings Corporation is not included in the NASDAQ 100 index
Is Envista Holdings Corporation in the Dow Jones?
No, Envista Holdings Corporation is not included in the Dow Jones index
When was Envista Holdings Corporation last earnings report?
Envista Holdings Corporation's most recent earnings report was on October 29, 2025
When does Envista Holdings Corporation report earnings?
The next expected earnings date for Envista Holdings Corporation is February 5, 2026